Medicare Enrolled
Dr. Deborah Sambucci, D.O.
Cardiovascular Disease · Haddon Heights, NJ
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sambucci from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sambucci?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sambucci
Dr. Deborah Sambucci is a cardiovascular disease specialist in Haddon Heights, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sambucci performed 7,934 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sambucci received a total of $6,975 from 33 pharmaceutical and/or device companies across 464 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sambucci is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 4% volume in NJ
$6,975 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,934
Medicare services
Top 4% in NJ for cardiovascular disease
Not available
Unique patients (not deduplicated)
$145
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,278 | $11 | $45 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,244 | $42 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
896 | $70 | $175 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
772 | $52 | $120 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
506 | $40 | $70 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
441 | $159 | $548 |
| Exercise or drug-induced heart stress test with ECG A test that monitors the heart's electrical activity while the patient exercises or receives medication to increase heart rate. |
330 | $30 | $143 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
329 | $12 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
301 | $98 | $248 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
293 | $16 | $120 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 269 | $614 | $1,022 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
250 | $2,186 | $4,900 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
123 | $7 | $30 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
118 | $205 | $509 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
109 | $87 | $215 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
108 | $7 | $25 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
85 | $78 | $109 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
84 | $137 | $396 |
| Heart muscle strain imaging | 81 | $33 | $85 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
78 | $385 | $961 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
49 | $59 | $279 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
43 | $741 | $2,400 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
42 | $20 | $50 |
| External counterpulsation, per treatment session | 36 | $93 | $320 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
20 | $134 | $375 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $153 | $340 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $100 | $335 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
13 | $62 | $332 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
5.8% high complexity
38.2% medium
56.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,975
Total received (2018-2024)
Avg $996/year across 7 years
Top 28% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
464
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,488
2023
$577
2022
$899
2021
$814
2020
$1,140
2019
$1,083
2018
$974
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$401
Impulse Dynamics (USA) Inc.
$216
E.R. Squibb & Sons, L.L.C.
$188
Janssen Pharmaceuticals, Inc
$145
Abbott Laboratories
$107
Amgen Inc.
$63
PFIZER INC.
$60
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$60
Boston Scientific Corporation
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
SCPHARMACEUTICALS INC.
$33
CVRx, Inc.
$32
Actelion Pharmaceuticals US, Inc.
$31
Medtronic, Inc.
$22
Alnylam Pharmaceuticals Inc.
$18
Esperion Therapeutics, Inc.
$15
AstraZeneca Pharmaceuticals LP
$14
Top 3 companies account for 54.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,006
Novartis Pharmaceuticals Corporation
$884
Amgen Inc.
$774
Abbott Laboratories
$516
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$417
PFIZER INC.
$408
Esperion Therapeutics, Inc.
$366
E.R. Squibb & Sons, L.L.C.
$351
Impulse Dynamics (USA) Inc.
$334
AstraZeneca Pharmaceuticals LP
$316
SANOFI-AVENTIS U.S. LLC
$239
Merck Sharp & Dohme LLC
$183
Amarin Pharma Inc.
$170
W. L. Gore & Associates, Inc.
$144
Kowa Pharmaceuticals America, Inc.
$125
Regeneron Healthcare Solutions, Inc.
$120
Boston Scientific Corporation
$114
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
Bayer HealthCare Pharmaceuticals Inc.
$56
CVRx, Inc.
$48
Actelion Pharmaceuticals US, Inc.
$46
SCPHARMACEUTICALS INC.
$33
Merck Sharp & Dohme Corporation
$28
Gilead Sciences, Inc.
$27
ARBOR PHARMACEUTICALS, INC.
$27
Medtronic, Inc.
$22
Lexicon Pharmaceuticals, Inc.
$22
Alnylam Pharmaceuticals Inc.
$18
Regeneron Pharmaceuticals, Inc.
$17
Daiichi Sankyo Inc.
$16
GENZYME CORPORATION
$15
Otsuka America Pharmaceutical, Inc.
$15
Preventice Services, LLC
$13
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
ABRE · AMVUTTRA · AVEIR · Alere i · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CARDIOMEMS · CHANTIX · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · FABRAZYME · FARXIGA · FORTIFY ASSURA · FUROSCIX · GORE CARDIOFORM Septal Occluder · HeartMate · HeartMate 3 Left Ventricular Dev · INJECTAFER · Inpefa · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LifeVest · Livalo · MULTAQ · NEXLETOL · NEXLIZET · OPSUMIT · OPTIMIZER · Optimizer · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Ranexa · Repatha · SAMSCA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
663
County median income
$86,384
Nearest hospital to ZIP centroid (approximate)
JEFFERSON STRATFORD HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sambucci is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 4% in NJ), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sambucci experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Sambucci performed 1,278 electrocardiogram (ekg), 12-lead services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sambucci receive payments from pharmaceutical companies?
Yes. Dr. Sambucci received a total of $6,975 from 33 companies across 464 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sambucci's costs compare to other cardiologists in Haddon Heights?
Dr. Sambucci's average Medicare payment per service is $145. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sambucci) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Haddon Heights
Browse cardiologists in Haddon Heights ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology